Literature DB >> 14194629

ANABOLIC RESPONSES OF DIAPHRAGM MUSCLE TO INSULIN AND TO OTHER PANCREATIC PROTEINS.

P RIESER, C H RIESER.   

Abstract

Entities:  

Keywords:  CARBOXYPEPTIDASES; CHYMOTRYPSIN; DIAPHRAGM; EXPERIMENTAL LAB STUDY; GLUCOSE METABOLISM; GLYCOGEN; HYDROLASES; INSULIN; METABOLISM; MUSCLE, SMOOTH; PEPSIN; PEPTIDE PEPTIDOHYDROLASES; PHARMACOLOGY; PROLINE; RATS; SERINE; TRYPSIN; XYLOSE

Mesh：

Substances：

Year:  1964        PMID： 14194629     DOI： 10.3181/00379727-116-29339

Source DB:  PubMed          Journal:  Proc Soc Exp Biol Med        ISSN： 0037-9727


× No keyword cloud information.
  15 in total

Review 1.  Targeting proteinase-activated receptors: therapeutic potential and challenges.

Authors:  Rithwik Ramachandran; Farshid Noorbakhsh; Kathryn Defea; Morley D Hollenberg
Journal:  Nat Rev Drug Discov       Date:  2012-01-03       Impact factor: 84.694

Review 2.  Proteinases and signalling: pathophysiological and therapeutic implications via PARs and more.

Authors:  R Ramachandran; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2007-12-03       Impact factor: 8.739

Review 3.  Biased signalling and proteinase-activated receptors (PARs): targeting inflammatory disease.

Authors:  M D Hollenberg; K Mihara; D Polley; J Y Suen; A Han; D P Fairlie; R Ramachandran
Journal:  Br J Pharmacol       Date:  2014-03       Impact factor: 8.739

Review 4.  Proteinases, their receptors and inflammatory signalling: the Oxford South Parks Road connection.

Authors:  M D Hollenberg
Journal:  Br J Pharmacol       Date:  2015-03-17       Impact factor: 8.739

5.  Insulin stimulates the generation of an adipocyte phosphoprotein that is isolated with a monoclonal antibody against the regulatory subunit of bovine heart cAMP-dependent protein kinase.

Authors:  J C Lawrence; J F Hiken; M Inkster; C W Scott; M C Mumby
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

6.  Perivascular adipose tissue-derived relaxing factors: release by peptide agonists via proteinase-activated receptor-2 (PAR2) and non-PAR2 mechanisms.

Authors:  Y Li; K Mihara; M Saifeddine; A Krawetz; D C W Lau; H Li; H Ding; C R Triggle; M D Hollenberg
Journal:  Br J Pharmacol       Date:  2011-12       Impact factor: 8.739

7.  The nature of human serum insulin-like activity (ILA)P Characterization of ILA in serum and serum fractions obtained by acid-ethanol extraction and adsorption chromatography.

Authors:  P L Poffenbarger; J W Ensinck; D K Hepp; R H Williams
Journal:  J Clin Invest       Date:  1968-02       Impact factor: 14.808

8.  [Insulin receptors and membrane transport in muscle].

Authors:  J M Maturo; P Rieser
Journal:  Acta Diabetol Lat       Date:  1968 Jan-Mar

9.  Modulation of growth and function of human gingival fibroblasts by fibroblast-activating factor derived from Porphyromonas gingivalis W50.

Authors:  J Mihara; Y Miyazawa; S C Holt
Journal:  Infect Immun       Date:  1993-02       Impact factor: 3.441

Review 10.  Proteinases, proteinase-activated receptors (PARs) and the pathophysiology of cancer and diseases of the cardiovascular, musculoskeletal, nervous and gastrointestinal systems.

Authors:  Kristina K Hansen; Katerina Oikonomopoulou; Yang Li; Morley D Hollenberg
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-10-19       Impact factor: 3.000
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.